VIVE vs. HTGMQ, ONCSQ, KLDO, GNCA, VRAYQ, TIVC, NUWE, NDRA, HSDT, and BSGM
Should you be buying Viveve Medical stock or one of its competitors? The main competitors of Viveve Medical include HTG Molecular Diagnostics (HTGMQ), OncoSec Medical (ONCSQ), Kaleido Biosciences (KLDO), Genocea Biosciences (GNCA), ViewRay (VRAYQ), Tivic Health Systems (TIVC), Nuwellis (NUWE), ENDRA Life Sciences (NDRA), Helius Medical Technologies (HSDT), and BioSig Technologies (BSGM). These companies are all part of the "medical" sector.
HTG Molecular Diagnostics (NASDAQ:HTGMQ) and Viveve Medical (NASDAQ:VIVE) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, valuation, earnings, media sentiment, analyst recommendations, profitability, risk, community ranking and dividends.
HTG Molecular Diagnostics has a beta of 2.97, meaning that its share price is 197% more volatile than the S&P 500. Comparatively, Viveve Medical has a beta of 0.08, meaning that its share price is 92% less volatile than the S&P 500.
HTG Molecular Diagnostics has higher earnings, but lower revenue than Viveve Medical.
Viveve Medical received 311 more outperform votes than HTG Molecular Diagnostics when rated by MarketBeat users.
In the previous week, Viveve Medical had 1 more articles in the media than HTG Molecular Diagnostics. MarketBeat recorded 1 mentions for Viveve Medical and 0 mentions for HTG Molecular Diagnostics. Viveve Medical's average media sentiment score of 0.00 equaled HTG Molecular Diagnostics'average media sentiment score.
Summary
HTG Molecular Diagnostics and Viveve Medical tied by winning 3 of the 6 factors compared between the two stocks.
Get Viveve Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for VIVE and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding VIVE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Viveve Medical Competitors List
Related Companies and Tools
